Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) has issued an update.
Kilitch Drugs (India) Limited has announced its 33rd Annual General Meeting (AGM) scheduled for September 26, 2025, to be conducted via video conferencing. The AGM will address ordinary business such as the adoption of financial statements and the reappointment of directors, including Mr. Bhavin Mehta and Mr. Mukund Mehta, the latter as Managing Director for another five years. This meeting is significant for stakeholders as it involves key decisions on leadership and financial strategies that could impact the company’s future operations and market positioning.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of drugs and related healthcare products. The company is based in Mumbai, India, and is known for its contributions to the pharmaceutical sector, often referred to as the ‘Pharmacy of the World.’
Average Trading Volume: 2,427
Technical Sentiment Signal: Hold
Current Market Cap: 5.91B INR
For detailed information about KILITCH stock, go to TipRanks’ Stock Analysis page.